Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-04

FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved Mylan Institutional LLC's original application for norepinephrine bitartrate injections (generic) as a vasopressor to treat life-threatening hypote…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norepinephrine bitartrate (Norepinephrine bitartrate)

Snippet

ORIG AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)